Ladenburg Thalmann Financial Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$1.8M	Buy	56,130 +1,469	+3%	+$494K	0.01%	936
2019 Q3	$1.35M	Buy	54,661 +50,574	+1,237%	+$15M	0.01%	1035
2019 Q2	$1.28M	Sell	4,087 -989	-19%	-$329K	0.01%	1051
2019 Q1	$2.09M	Buy	5,076 +121	+2%	+$49.8K	0.02%	749
2018 Q4	$1.85M	Buy	4,955 +126	+3%	+$46.1K	0.02%	703
2018 Q3	$1.95M	Buy	4,829 +961	+25%	+$366K	0.02%	740
2018 Q2	$1.33M	Hold	3,868	–	–	0.01%	899
2018 Q1	$1.33M	Buy	3,868 +189	+5%	+$65.7K	0.01%	899
2017 Q4	$1.38M	Sell	3,679 -10	-0.3%	-$4.05K	0.01%	874
2017 Q3	$1.65M	Sell	3,689 -782	-17%	-$372K	0.02%	722
2017 Q2	$2.2M	Buy	4,471 +281	+7%	+$123K	0.03%	552
2017 Q1	$1.62M	Buy	4,190 +221	+6%	+$81.9K	0.02%	658
2016 Q4	$1.46M	Buy	3,969 +575	+17%	+$219K	0.02%	654
2016 Q3	$1.36M	Buy	3,394 +529	+18%	+$212K	0.02%	639
2016 Q2	$1M	Buy	2,865 +307	+12%	+$118K	0.02%	755
2016 Q1	$946K	Sell	2,558 -296	-10%	-$122K	0.02%	730
2015 Q4	$1.55M	Sell	2,854 -523	-15%	-$283K	0.03%	492
2015 Q3	$1.56M	Buy	3,377 +135	+4%	+$72.5K	0.03%	460
2015 Q2	$1.65M	Sell	3,242 -51	-2%	-$24.9K	0.03%	485
2015 Q1	$1.49M	Buy	3,293 +875	+36%	+$371K	0.03%	514
2014 Q4	$992K	Buy	2,418 +319	+15%	+$125K	0.02%	604
2014 Q3	$757K	Buy	2,099 +109	+5%	+$36.5K	0.02%	618
2014 Q2	$562K	Sell	1,990 -1,697	-46%	-$503K	0.02%	731
2014 Q1	$1.11M	Buy	3,687 +198	+6%	+$61K	0.03%	425
2013 Q4	$960K	Buy	3,489 +1,890	+118%	+$544K	0.03%	454
2013 Q3	$500K	Buy	1,599 +168	+12%	+$44.2K	0.02%	663
2013 Q2	$322K	Buy	+1,431	New	+$333K	0.01%	788